The development of lhermitte's sign during cisplatin chemotherapy: Possible drug‐induced toxicity causing spinal cord demyelination

57Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cisplatin is a recognized neurotoxic agent that commonly causes ototoxicity and peripheral neuropathy. In conjunction with characteristic peripheral neuropathy, two patients treated with high‐dose cisplatin developed Lhermitte's sign, a manifestation of posterior column spinal cord pathology. After cisplatin therapy was stopped, this symptom gradually resolved. This suggests that at high doses cisplatin may also cause demyelinating central nervous system lesions involving the spinal cord. Copyright © 1987 American Cancer Society

Cite

CITATION STYLE

APA

Walther, P. J., Jr, E. R., & Bullard, D. E. (1987). The development of lhermitte’s sign during cisplatin chemotherapy: Possible drug‐induced toxicity causing spinal cord demyelination. Cancer, 60(9), 2170–2172. https://doi.org/10.1002/1097-0142(19871101)60:9<2170::AID-CNCR2820600909>3.0.CO;2-N

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free